A dealership's rating is based on all of their reviews, with more weight given to recent reviews. Includes reviews of Nash Chevrolet from DealerRater. Want to share your experience with this ...
Around this time last year, Akero was riding high on positive phase 2b data for its candidate non-alcoholic steatohepatitis (NASH) therapy, but new data has dented optimism about the project. Results ...
Intercept Pharmaceuticals has accused the FDA of moving the goalposts during its review of a potential blockbuster drug for the fatty liver disease known as NASH following a rejection. Intercept’s CEO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback